<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>39(9)</volume><submitter>Panthier F</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Kidney Stone Calculator (KSC) is a free, three-dimensional (3D) planning software for flexible ureteroscopy(fURS) with Holmium:YAG(Ho:YAG) endocorporeal lithotripsy (EL). KSC provides the stone volume (SV) and expected duration of lithotripsy (ExDL) estimations based on non-enhanced-CT scan (NECT) DICOM series. We aimed to provide a preclinical and clinical evaluation of KSC.&lt;h4>Patients and methods&lt;/h4>A preclinical evaluation measured the SV by three operators (resident, endourology expert and research engineer) among 17 NECT cases. Between January and March 2020, a multicentric, prospective, observational double-blind clinical evaluation was conducted in patients presenting with renal stones treated with Ho:YAG-EL during fURS and preoperative NECT. Demographic and surgical data were collected. The primary endpoint was a significant median difference between ExDL and EffectiveDL (EfDL). Second, efficiency (J/mm&lt;sup>3&lt;/sup>) and efficacy (mm&lt;sup>3&lt;/sup>/min) ratios were calculated.&lt;h4>Results&lt;/h4>The preclinical evaluation showed no significant difference in the SV measurements among operators (p > 0.05). Pearson and Kendall coefficients of 0.99 and 0.98, respectively, were found. Twenty-six patients were included in the clinical evaluation, with a median age of 55 years. In 66% of cases, there was a single stone located in the lower pole, with a density > 1000 Hounsfield Unit observed in 42% and 85% of cases. A 14% [Q1-Q3 (5.4-24.8); p = 0.36] median difference between ExDL and EfDL was noted, which was greater in the case of lower pole stones with no possible relocation (p = 0.008). Median values of 17.6 J/mm&lt;sup>3&lt;/sup> and 0.4 (0.32-0.56) mm&lt;sup>3&lt;/sup>/s EL were also noted.&lt;h4>Conclusions&lt;/h4>Kidney Stone Calculator is a reproducible and accurate software that allows for an estimation of the stone burden and provides an ExDL for URSf. Defining the influencing factors of EL will improve its ExDL.</pubmed_abstract><journal>World journal of urology</journal><pagination>3607-3614</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8006641</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Evaluation of a free 3D software for kidney stones' surgical planning: "kidney stone calculator" a pilot study.</pubmed_title><pmcid>PMC8006641</pmcid><pubmed_authors>Berthe L</pubmed_authors><pubmed_authors>Doizi S</pubmed_authors><pubmed_authors>Yonneau L</pubmed_authors><pubmed_authors>Lebret T</pubmed_authors><pubmed_authors>Traxer O</pubmed_authors><pubmed_authors>Illoul L</pubmed_authors><pubmed_authors>Timsit MO</pubmed_authors><pubmed_authors>Audenet F</pubmed_authors><pubmed_authors>Panthier F</pubmed_authors><pubmed_authors>Mejean A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluation of a free 3D software for kidney stones' surgical planning: "kidney stone calculator" a pilot study.</name><description>&lt;h4>Introduction&lt;/h4>Kidney Stone Calculator (KSC) is a free, three-dimensional (3D) planning software for flexible ureteroscopy(fURS) with Holmium:YAG(Ho:YAG) endocorporeal lithotripsy (EL). KSC provides the stone volume (SV) and expected duration of lithotripsy (ExDL) estimations based on non-enhanced-CT scan (NECT) DICOM series. We aimed to provide a preclinical and clinical evaluation of KSC.&lt;h4>Patients and methods&lt;/h4>A preclinical evaluation measured the SV by three operators (resident, endourology expert and research engineer) among 17 NECT cases. Between January and March 2020, a multicentric, prospective, observational double-blind clinical evaluation was conducted in patients presenting with renal stones treated with Ho:YAG-EL during fURS and preoperative NECT. Demographic and surgical data were collected. The primary endpoint was a significant median difference between ExDL and EffectiveDL (EfDL). Second, efficiency (J/mm&lt;sup>3&lt;/sup>) and efficacy (mm&lt;sup>3&lt;/sup>/min) ratios were calculated.&lt;h4>Results&lt;/h4>The preclinical evaluation showed no significant difference in the SV measurements among operators (p > 0.05). Pearson and Kendall coefficients of 0.99 and 0.98, respectively, were found. Twenty-six patients were included in the clinical evaluation, with a median age of 55 years. In 66% of cases, there was a single stone located in the lower pole, with a density > 1000 Hounsfield Unit observed in 42% and 85% of cases. A 14% [Q1-Q3 (5.4-24.8); p = 0.36] median difference between ExDL and EfDL was noted, which was greater in the case of lower pole stones with no possible relocation (p = 0.008). Median values of 17.6 J/mm&lt;sup>3&lt;/sup> and 0.4 (0.32-0.56) mm&lt;sup>3&lt;/sup>/s EL were also noted.&lt;h4>Conclusions&lt;/h4>Kidney Stone Calculator is a reproducible and accurate software that allows for an estimation of the stone burden and provides an ExDL for URSf. Defining the influencing factors of EL will improve its ExDL.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2024-11-09T10:45:19.257Z</modification><creation>2022-02-09T12:50:53.969Z</creation></dates><accession>S-EPMC8006641</accession><cross_references><pubmed>33779821</pubmed><doi>10.1007/s00345-021-03671-z</doi></cross_references></HashMap>